Carolyn J. Barg

TL;DR: The findings suggest that integrating WG/ES into NBS might reduce participation, and challenge the moral authority that NBS programmes rely upon to ensure population benefits, and point to the need for caution in the untargeted use of WG-ES in public health contexts.

TL;DR: Although immediate distress was reported among mothers of FP infants, selected psychometric tools did not detect these concerns and the screening system reflected herein may be a model for NBS programs working to minimize FP-related psychosocial harm.

TL;DR: Inconclusive CF NBS results were not associated with anxiety or vulnerability but led to health‐related uncertainty and qualitative concerns, which should be considered alongside efforts to optimize protocols for CF screening and surveillance.

TL;DR: While aiming to go beyond price in the acquisition of most medical technologies, procurement adopts a narrow approach to assessing quality and costs, but also attends to factors little considered by HTA, suggesting opportunities for mutual lesson learning.

TL;DR: Support for newborn screening policies prioritizing clinical benefits over solely informational benefits is suggested, coupled with concerted efforts to avoid or minimize harms.